SemaPhore | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

8 results for “SemaPhore”

Trials

Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE

113 participants · First posted Sep 20, 2016

Lysyl Oxidase, Semaphorin 7a and Semaphorin 3a in Patients With Systemic Sclerosis

30 participants · First posted Sep 17, 2013

Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASH

148 participants · First posted Jun 30, 2016

Drugs

semaphorin 3A antagonists

Research programme: iron chelators - MetaPhore

News

Altamira Therapeutics Advances RNA Delivery Platform Through Strategic Spin-Off and Circular RNA Innovation

Altamira Therapeutics Expands xPhore Platform with Successful DNA Delivery Technology

Altamira Therapeutics Expands Nucleic Acid Delivery Platform with DNA Technology and Advances Spin-off Plans